Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection

BACKGROUND: mRNA coronavirus disease 2019 (COVID-19) vaccines are safe and effective, but increasing reports of breakthrough infections highlight the need to vigilantly monitor and compare the effectiveness of these vaccines. METHODS: We retrospectively compared protection against symptomatic infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Puranik, Arjun, Lenehan, Patrick J., Silvert, Eli, Niesen, Michiel J.M., Corchado-Garcia, Juan, O’Horo, John C., Virk, Abinash, Swift, Melanie D., Gordon, Joel E., Speicher, Leigh Lewis, Geyer, Holly L., Kremers, Walter, Halamka, John, Badley, Andrew D., Venkatakrishnan, A.J., Soundararajan, Venky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Clinical Advances
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664708/
https://www.ncbi.nlm.nih.gov/pubmed/34927113
http://dx.doi.org/10.1016/j.medj.2021.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664708/
https://www.ncbi.nlm.nih.gov/pubmed/34927113
http://dx.doi.org/10.1016/j.medj.2021.12.002

Ejemplares similares